계산
총 자산 회전율 | = | 수익1 | ÷ | 총 자산1 | |
---|---|---|---|---|---|
2021. 12. 31. | 0.46 | = | 10,981,700) | ÷ | 23,877,300) |
2020. 12. 31. | 0.55 | = | 13,444,600) | ÷ | 24,618,900) |
2019. 12. 31. | 0.53 | = | 14,377,900) | ÷ | 27,234,300) |
2018. 12. 31. | 0.53 | = | 13,452,900) | ÷ | 25,288,900) |
2017. 12. 31. | 0.52 | = | 12,273,900) | ÷ | 23,652,600) |
2016. 12. 31. | 0.50 | = | 11,448,800) | ÷ | 22,876,800) |
2015. 12. 31. | 0.55 | = | 10,763,800) | ÷ | 19,504,800) |
2014. 12. 31. | 0.68 | = | 9,703,324) | ÷ | 14,316,559) |
2013. 12. 31. | 0.58 | = | 6,932,199) | ÷ | 11,863,335) |
2012. 12. 31. | 0.54 | = | 5,516,461) | ÷ | 10,130,118) |
2011. 12. 31. | 0.56 | = | 5,048,634) | ÷ | 9,049,604) |
2010. 12. 31. | 0.58 | = | 4,716,423) | ÷ | 8,092,493) |
2009. 12. 31. | 0.51 | = | 4,377,348) | ÷ | 8,551,854) |
2008. 12. 31. | 0.48 | = | 4,097,507) | ÷ | 8,478,991) |
2007. 12. 31. | 0.37 | = | 3,171,617) | ÷ | 8,628,815) |
2006. 12. 31. | 0.31 | = | 2,683,049) | ÷ | 8,552,808) |
2005. 12. 31. | 0.29 | = | 2,422,500) | ÷ | 8,366,947) |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위 천
경쟁사와의 비교
Biogen Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021. 12. 31. | 0.46 | 0.38 | 0.40 | 0.42 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.72 | 0.45 | 0.63 | 0.41 |
2020. 12. 31. | 0.55 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.03 | 0.27 | 0.50 | 0.47 |
2019. 12. 31. | 0.53 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.00 | 0.31 | 0.53 | 0.44 |
2018. 12. 31. | 0.53 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.00 | 0.34 | 0.57 | 0.43 |
2017. 12. 31. | 0.52 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | — | 0.31 | 0.67 | 0.37 |
2016. 12. 31. | 0.50 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | — | 0.31 | 0.70 | 0.40 |
2015. 12. 31. | 0.55 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | — | 0.29 | 0.73 | 0.41 |
2014. 12. 31. | 0.68 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | — | 0.29 | 0.73 | 0.39 |
2013. 12. 31. | 0.58 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | — | 0.30 | 0.71 | 0.41 |
2012. 12. 31. | 0.54 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | — | 0.32 | 0.66 | 0.46 |
2011. 12. 31. | 0.56 | — | 0.31 | 0.64 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | — | 0.36 | 0.34 | 0.44 |
2010. 12. 31. | 0.58 | — | 0.34 | 0.63 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | — | 0.35 | 0.42 | 0.51 |
2009. 12. 31. | 0.51 | — | 0.36 | 0.61 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | — | 0.23 | 0.51 | 0.47 |
2008. 12. 31. | 0.48 | — | 0.40 | 0.70 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | — | 0.43 | 0.36 | 0.50 |
2007. 12. 31. | 0.37 | — | 0.41 | 0.74 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | — | 0.42 | 0.13 | 0.46 |
2006. 12. 31. | 0.31 | — | 0.41 | 0.70 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | — | 0.42 | 0.11 | 0.18 |
2005. 12. 31. | 0.29 | — | 0.41 | 0.68 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | — | 0.44 | 0.16 | 0.62 |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Biogen Inc. | 제약, 생명공학 및 생명과학 | |
---|---|---|
2021. 12. 31. | 0.46 | 0.45 |
2020. 12. 31. | 0.55 | 0.38 |
2019. 12. 31. | 0.53 | 0.39 |
2018. 12. 31. | 0.53 | 0.45 |
2017. 12. 31. | 0.52 | 0.40 |
2016. 12. 31. | 0.50 | 0.41 |
2015. 12. 31. | 0.55 | 0.42 |
2014. 12. 31. | 0.68 | 0.45 |
2013. 12. 31. | 0.58 | 0.43 |
2012. 12. 31. | 0.54 | 0.45 |
2011. 12. 31. | 0.56 | 0.46 |
2010. 12. 31. | 0.58 | 0.47 |
2009. 12. 31. | 0.51 | 0.39 |
2008. 12. 31. | 0.48 | 0.57 |
2007. 12. 31. | 0.37 | 0.56 |
2006. 12. 31. | 0.31 | 0.54 |
2005. 12. 31. | 0.29 | 0.57 |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Biogen Inc. | 의료 | |
---|---|---|
2021. 12. 31. | 0.46 | 0.76 |
2020. 12. 31. | 0.55 | 0.70 |
2019. 12. 31. | 0.53 | 0.71 |
2018. 12. 31. | 0.53 | 0.67 |
2017. 12. 31. | 0.52 | 0.68 |
2016. 12. 31. | 0.50 | 0.70 |
2015. 12. 31. | 0.55 | 0.67 |
2014. 12. 31. | 0.68 | 0.72 |
2013. 12. 31. | 0.58 | 0.69 |
2012. 12. 31. | 0.54 | 0.69 |
2011. 12. 31. | 0.56 | 0.70 |
2010. 12. 31. | 0.58 | 0.69 |
2009. 12. 31. | 0.51 | 0.64 |
2008. 12. 31. | 0.48 | 0.81 |
2007. 12. 31. | 0.37 | 0.77 |
2006. 12. 31. | 0.31 | 0.74 |
2005. 12. 31. | 0.29 | 0.70 |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).